See more : Taiyo Yuden Co., Ltd. (TYOYY) Income Statement Analysis – Financial Results
Complete financial analysis of Precision Optics Corporation, Inc. (POCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Precision Optics Corporation, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Tara Chand Infra Soln Ltd (TARACHAND.NS) Income Statement Analysis – Financial Results
- Pinnacle Bank (PBNK) Income Statement Analysis – Financial Results
- Silver Hammer Mining Corp. (HAMRF) Income Statement Analysis – Financial Results
- Sinoma International Engineering Co.Ltd (600970.SS) Income Statement Analysis – Financial Results
- Ami Organics Limited (AMIORG.NS) Income Statement Analysis – Financial Results
Precision Optics Corporation, Inc. (POCI)
About Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.10M | 21.04M | 15.68M | 10.67M | 9.92M | 6.80M | 4.04M | 3.15M | 3.92M | 3.91M | 3.65M | 2.52M | 2.15M | 2.25M | 3.09M | 3.53M | 2.90M | 2.48M | 2.28M | 1.35M | 1.46M | 2.40M | 1.77M | 4.25M | 3.01M | 3.00M | 4.10M | 7.40M | 8.10M | 7.60M | 7.10M | 4.80M | 5.80M | 4.40M |
| Cost of Revenue | 13.31M | 13.31M | 10.75M | 7.24M | 6.56M | 4.68M | 2.56M | 2.38M | 2.97M | 3.11M | 2.85M | 1.87M | 1.59M | 1.49M | 1.80M | 1.93M | 2.11M | 2.00M | 2.28M | 2.00M | 2.06M | 2.07M | 3.12M | 3.44M | 1.48M | 1.80M | 3.20M | 5.20M | 5.30M | 4.80M | 5.20M | 3.20M | 4.10M | 3.40M |
| Gross Profit | 5.80M | 7.73M | 4.93M | 3.43M | 3.36M | 2.12M | 1.48M | 773.72K | 942.02K | 798.27K | 800.80K | 654.43K | 557.41K | 752.12K | 1.30M | 1.60M | 792.00K | 475.27K | 4.06K | -647.77K | -597.94K | 326.98K | -1.35M | 809.15K | 1.53M | 1.20M | 900.00K | 2.20M | 2.80M | 2.80M | 1.90M | 1.60M | 1.70M | 1.00M |
| Gross Profit Ratio | 30.35% | 36.75% | 31.43% | 32.17% | 33.89% | 31.19% | 36.70% | 24.53% | 24.05% | 20.41% | 21.93% | 25.97% | 25.90% | 33.50% | 41.92% | 45.22% | 27.29% | 19.18% | 0.18% | -47.99% | -40.82% | 13.63% | -76.03% | 19.05% | 50.68% | 40.00% | 21.95% | 29.73% | 34.57% | 36.84% | 26.76% | 33.33% | 29.31% | 22.73% |
| Research & Development | 981.78K | 992.38K | 666.48K | 624.25K | 886.13K | 505.30K | 456.38K | 464.16K | 478.27K | 492.94K | 471.11K | 630.29K | 664.70K | 825.03K | 529.41K | 737.79K | 757.85K | 1.31M | 859.94K | 1.14M | 1.32M | 1.24M | 2.27M | 3.22M | 1.69M | 900.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.54M | 7.38M | 5.61M | 3.71M | 3.90M | 2.10M | 1.37M | 1.31M | 1.55M | 1.55M | 1.50M | 1.26M | 1.19M | 958.51K | 1.19M | 1.45M | 1.87M | 2.10M | 1.62M | 1.86M | 1.73M | 1.88M | 2.08M | 2.10M | 1.76M | 1.60M | 2.60M | 2.30M | 2.10M | 1.90M | 1.80M | 2.90M | 1.70M | 700.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | -7.61K | 0.00 | -5.79K | -6.11K | -14.84K | 22.05K | 35.17K | 0.00 | 76.15K | 0.00 | -39.52K | -20.83K | -48.75K | -210.55K | 0.00 | -165.70K | 0.00 | 0.00 | 195.81K | 4.45M | 0.00 | 481.57K | 400.00K | 400.00K | 400.00K | 300.00K | 200.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Operating Expenses | 8.52M | 8.37M | 6.28M | 4.34M | 4.79M | 2.61M | 1.83M | 1.78M | 2.03M | 2.04M | 1.97M | 1.89M | 1.85M | 1.74M | 1.70M | 2.14M | 2.41M | 3.41M | 2.31M | 3.00M | 3.05M | 3.31M | 8.80M | 5.32M | 3.94M | 2.90M | 3.00M | 2.70M | 2.40M | 2.10M | 1.90M | 3.00M | 1.80M | 800.00K |
| Cost & Expenses | 21.83M | 21.68M | 17.03M | 11.58M | 11.35M | 7.29M | 4.39M | 4.16M | 5.00M | 5.15M | 4.82M | 3.76M | 3.45M | 3.24M | 3.50M | 4.07M | 4.52M | 5.41M | 4.59M | 5.00M | 5.11M | 5.38M | 11.92M | 8.76M | 5.42M | 4.70M | 6.20M | 7.90M | 7.70M | 6.90M | 7.10M | 6.20M | 5.90M | 4.20M |
| Interest Income | 0.00 | 218.93K | 155.66K | 5.30K | 1.00K | 1.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 535.00 | 207.00 | 901.00 | 5.21K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 225.11K | 218.93K | 155.66K | 5.30K | 1.00K | 1.42K | 1.86K | 3.14K | 469.00 | 0.00 | 0.00 | 1.41K | 30.21K | 60.00K | 256.73K | 453.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 212.38K | 210.74K | 245.24K | 146.80K | 112.22K | 38.55K | 27.22K | 33.66K | 25.86K | 21.27K | 20.02K | 20.97K | 23.37K | 57.61K | 79.04K | 62.20K | 161.17K | 120.40K | 130.11K | 241.97K | 240.85K | 265.10K | 593.49K | 730.50K | 481.57K | 400.00K | 400.00K | 400.00K | 300.00K | 200.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| EBITDA | -2.51M | -427.81K | -526.57K | 50.18K | -1.31M | -573.99K | -321.40K | -968.74K | -1.01M | -1.22M | -1.15M | -1.76M | 1.02M | -934.10K | -324.20K | -475.23K | -1.46M | -2.81M | -2.14M | -3.45M | -3.41M | -2.72M | -9.55M | -3.78M | -1.93M | -1.30M | -1.70M | -100.00K | 700.00K | 900.00K | 100.00K | -1.30M | 0.00 | 300.00K |
| EBITDA Ratio | -13.15% | -2.03% | -7.41% | -7.11% | -13.21% | -6.55% | -7.96% | -30.76% | -27.12% | -32.75% | -31.60% | -48.26% | -59.05% | -41.61% | -10.48% | -13.47% | -57.60% | -113.60% | -102.57% | -245.74% | -229.08% | -105.22% | -287.79% | -88.97% | -64.10% | -43.33% | -46.34% | -1.35% | 8.64% | 10.53% | 1.41% | -29.17% | -1.72% | 6.82% |
| Operating Income | -2.72M | -638.55K | -1.35M | -905.58K | -1.42M | -484.43K | -348.62K | -1.00M | -1.06M | -1.21M | -1.16M | -1.23M | -1.28M | -991.91K | -404.14K | -542.64K | -1.62M | -2.93M | -2.31M | -3.74M | -3.70M | -2.99M | -10.14M | -4.51M | -2.41M | -1.70M | -2.10M | -500.00K | 400.00K | 700.00K | 0.00 | -1.40M | -100.00K | 200.00K |
| Operating Income Ratio | -14.26% | -3.03% | -8.62% | -8.48% | -14.34% | -7.12% | -8.63% | -31.78% | -26.95% | -31.01% | -31.76% | -48.91% | -59.69% | -44.18% | -13.06% | -15.38% | -55.90% | -118.46% | -101.02% | -276.93% | -252.65% | -124.43% | -571.77% | -106.16% | -80.10% | -56.67% | -51.22% | -6.76% | 4.94% | 9.21% | 0.00% | -29.17% | -1.72% | 4.55% |
| Total Other Income/Expenses | -225.11K | 495.87K | 424.30K | 803.66K | -1.00K | -1.42K | -1.86K | -3.14K | 21.58K | 35.17K | 0.00 | -549.76K | 2.25M | -59.79K | -255.83K | -448.59K | -48.00 | 46.01K | 36.33K | -38.94K | 18.04K | 58.55K | 172.28K | 768.54K | 255.66K | 0.00 | 200.00K | 200.00K | 0.00 | 100.00K | 0.00 | 100.00K | -100.00K | 0.00 |
| Income Before Tax | -2.95M | -142.68K | -927.46K | -101.92K | -1.42M | -613.96K | -350.48K | -1.01M | -1.03M | -1.18M | -1.16M | -1.79M | 961.88K | -1.05M | -659.97K | -991.22K | -1.62M | -2.89M | -2.27M | -3.69M | -3.68M | -2.93M | -9.97M | -3.74M | -2.15M | 0.00 | -1.90M | -300.00K | 0.00 | 800.00K | 0.00 | -1.30M | -200.00K | 0.00 |
| Income Before Tax Ratio | -15.44% | -0.68% | -5.92% | -0.95% | -14.35% | -9.02% | -8.68% | -31.88% | -26.40% | -30.11% | -31.76% | -70.91% | 44.69% | -46.84% | -21.33% | -28.09% | -55.90% | -116.61% | -99.43% | -273.18% | -251.42% | -121.99% | -562.06% | -88.07% | -71.60% | 0.00% | -46.34% | -4.05% | 0.00% | 10.53% | 0.00% | -27.08% | -3.45% | 0.00% |
| Income Tax Expense | 1.94K | 1.94K | 952.00 | 912.00 | 2.17K | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 914.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 912.00 | 0.00 | -100.00K | 100.00K | 0.00 | 200.00K | 0.00 | -100.00K | -100.00K | 0.00 |
| Net Income | -2.95M | -144.61K | -928.42K | -102.84K | -1.43M | -614.87K | -351.39K | -1.01M | -1.03M | -1.18M | -1.16M | -1.79M | 960.97K | -1.05M | -660.88K | -992.14K | -1.62M | -2.89M | -2.27M | -3.69M | -3.68M | -2.93M | -9.97M | -3.74M | -2.16M | -1.70M | -2.00M | -400.00K | 400.00K | 600.00K | 0.00 | -1.30M | -100.00K | 200.00K |
| Net Income Ratio | -15.45% | -0.69% | -5.92% | -0.96% | -14.37% | -9.04% | -8.70% | -31.90% | -26.42% | -30.13% | -31.79% | -70.95% | 44.65% | -46.88% | -21.36% | -28.12% | -55.93% | -116.64% | -99.47% | -273.25% | -251.48% | -122.03% | -562.11% | -88.09% | -71.63% | -56.67% | -48.78% | -5.41% | 4.94% | 7.89% | 0.00% | -27.08% | -1.72% | 4.55% |
| EPS | -0.49 | -0.03 | -0.18 | -0.02 | -0.33 | -0.16 | -0.11 | -0.36 | -0.45 | -0.57 | -0.78 | -1.53 | 2.49 | -3.17 | -1.95 | -2.92 | -4.78 | -11.04 | -19.44 | -40.99 | -157.71 | -125.33 | -426.95 | -160.75 | -115.76 | -114.67 | -147.54 | -30.09 | 31.50 | 45.00 | 13.50 | -90.03 | -7.86 | 81.00 |
| EPS Diluted | -0.49 | -0.03 | -0.18 | -0.02 | -0.33 | -0.16 | -0.11 | -0.36 | -0.43 | -0.56 | -0.78 | -1.52 | 2.49 | -3.17 | -1.95 | -2.92 | -4.78 | -11.04 | -19.44 | -40.99 | -157.71 | -125.33 | -426.95 | -160.75 | -115.76 | -114.67 | -147.54 | -30.09 | 31.50 | 45.00 | 13.50 | -90.03 | -7.86 | 81.00 |
| Weighted Avg Shares Out | 6.07M | 5.67M | 5.30M | 4.43M | 4.33M | 3.83M | 3.28M | 2.78M | 2.30M | 2.07M | 1.49M | 1.17M | 387.92K | 331.59K | 339.47K | 339.47K | 339.44K | 261.67K | 116.92K | 89.99K | 23.36K | 23.36K | 23.36K | 23.28K | 18.62K | 14.83K | 13.56K | 13.29K | 13.59K | 13.33K | 11.11K | 14.44K | 12.72K | 9.52K |
| Weighted Avg Shares Out (Dil) | 6.07M | 5.67M | 5.30M | 4.43M | 4.33M | 3.83M | 3.28M | 2.78M | 2.39M | 2.09M | 1.49M | 1.17M | 425.31K | 331.59K | 339.47K | 339.47K | 339.44K | 261.67K | 116.92K | 89.99K | 23.36K | 23.36K | 23.36K | 23.28K | 18.62K | 14.83K | 13.56K | 13.29K | 13.59K | 13.33K | 11.11K | 14.44K | 12.72K | 9.52K |
Precision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Call Transcript
Precision Optics Corporation, Inc. (NASDAQ:POCI ) Q1 2025 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Robert Blum - IR, Lytham Partners Joe Forkey - CEO Wayne Coll - CFO Conference Call Participants Operator Good afternoon and...
Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program
Second single-use program to move into production this year highlights new growth opportunity for Precision Optics Second single-use program to move into production this year highlights new growth opportunity for Precision Optics
Precision Optics Reports First Quarter Fiscal Year 2025 Financial Results
Conference Call Scheduled for today, November 14, 2024, at 5:00pm ET. Conference Call Scheduled for today, November 14, 2024, at 5:00pm ET.
Precision Optics Corporation Schedules First Quarter of Fiscal Year 2025 Conference Call for November 14, 2024
GARDNER, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call...
Precision Optics Corporation, Inc. (POCI) Q4 2024 Earnings Call Transcript
Precision Optics Corporation, Inc. (NASDAQ:POCI ) Q4 2024 Earnings Call Transcript September 30, 2024 5:00 PM ET Company Participants Robert Blum - IR, Lytham Partners Joe Forkey - CEO Wayne Coll - CFO Operator Good afternoon, and welcome to the...
Precision Optics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Conference Call Scheduled for today, September 30, 2024, at 5:00pm ET. Conference Call Scheduled for today, September 30, 2024, at 5:00pm ET.
Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024
GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call...
Ophthalmic Lens and Precision Optics Manufacturing Machines Industry Research 2023-2030: Increasing Focus on Precision and Customization Sustains Growth in High-Performance Optics
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Lens and Precision Optics Manufacturing Machines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Ophthalmic Lens and Precision Optics Manufacturing Machines was valued...
Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing
GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice...
Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will participate...
Source: https://incomestatements.info
Category: Stock Reports